Lack of inducible nitric oxide synthase promotes intestinal tumorigenesis in the ApcMin/+ mouse

Gastroenterology

Volumn 121, Issue 4, 2001, Pages 889-899

  Scott, Daniel J ^a   Hull, Mark A ^a   Cartwright, Elizabeth J ^a   Lam, Wai K ^a   Tisbury, Alison ^a   Poulsom, Richard ^b   Markham, Alexander F ^a   Bonifer, Constanze ^a   Coletta, P Louise ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2; MESSENGER RNA; NITRIC OXIDE SYNTHASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARCINOGENESIS; COLON POLYPOSIS; CONTROLLED STUDY; CROSSING OVER; ENZYME ACTIVITY; ENZYME LOCALIZATION; FAMILIAL CANCER; GENOTYPE; INTESTINE CANCER; MACROPHAGE; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0034793607     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/gast.2001.27994     Document Type: Article

References (53)

1. Nitric oxide synthase in mammals
2. Chronic inflammation and reactive oxygen and nitrogen metabolism -implications in DNA damage and mutagenesis
3. DNA damage and mutation in human cells exposed to nitric oxide in vitro
4. The multifaceted roles of nitric oxide in cancer
5. Chemoprevention of colonic aberrant crypt foci by an inducible nitric oxide synthase-selective inhibitor
6. Suppression of azoxymethane-induced colonic aberrant crypt foci by a nitric oxide synthase inhibitor
7. Selective inhibition of inducible nitric oxide synthase inhibits tumor growth in vivo: Studies with 1400W, a novel inhibitor
8. Roles of nitric oxide in tumor growth
9. G-nitro-L-arginine methyl ester inhibits tumor-induced angiogenesis in mammary tumors
10. Demonstration of iNOS-mRNA and iNOS in human monocytes stimulated with cancer cells in vitro
11. Activated murine macrophages induce apoptosis in tumor cells through nitric oxide-dependent or -independent mechanisms
12. Transfection with the inducible nitric oxide synthase gene suppresses tumorigenicity and abrogates gene metastasis in K-1735 murine melanoma cells
13. Influence of nitric oxide synthase II gene disruption on tumor growth and metastasis
14. Frequent nitric oxide synthase-2 expression in human colon adenomas: Implication for tumor angiogenesis and colon cancer progression
15. Nitric oxide synthase activity and expression in human colorectal cancer
16. Aberrant expression of nitric oxide synthase in human polyps, neoplastic colonic mucosa and surrounding peritumoral normal mucosa
17. Expression of inducible nitric oxide synthase in colorectal cancer and its association with prognosis
18. Inducible nitric oxide synthase (iNOS) is expressed similarly in multiple aberrant crypt foci and colorectal tumors from the same patients
19. Effects of nitric oxide and nitric oxide-derived species on prostaglandin endoperoxide synthase and prostaglandin biosynthesis
20. Localization of cyclooxygenase-2 in human sporadic colorectal adenomas
21. Cyclooxygenase 2 is upregulated and localized to macrophages in the intestine of Min mice
22. Δ716 knockout mice by inhibition of cyclooxygenase 2 (Cox-2)
23. Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, against colon carcinogenesis
24. Superinduction of cyclooxygenase-2 by NO and agonist challenge involves transcriptional regulation mediated by AP-1 activation
25. Regulation of the expression of cyclooxygenase-2 by nitric oxide in rat peritoneal macrophages
26. Nitric oxide: A prostaglandin H synthase 1 and 2 reducing cosubstrate that does not stimulate cyclooxygenase activity or prostaglandin H synthase expression in murine macrophages
27. Regulation of prostaglandin biosynthesis by nitric oxide is revealed by targeted deletion of inducible nitric-oxide synthase
28. Nitric oxide activates cyclooxygenase enzymes
29. Interactions between inducible isoforms of nitric oxide synthase and cyclo-oxygenase in vivo: Investigations using the selective inhibitors, 1400W and celecoxib
30. A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse
31. Multiple intestinal neoplasia caused by a mutation in the murine homolog of the APC gene
32. Mice lacking inducible nitric oxide synthase are not resistant to lipopolysac-charide-induced death
33. Protective roles of nitric oxide and testosterone in endotoxaemia: Evidence from NOS-2-deficient mice
34. Inducible nitric oxide synthase (iNOS) gene deficiency increases the mortality of sepsis in mice
35. Tissue specific and position independent expression of the complete gene domain for chicken lysozyme in transgenic mice
36. An in vitro differentiation system for the examination of transgene activation in mouse macrophages
37. Functional macrophage cell lines transformed by Abelson leukaemia virus
38. Experimental ulceration leads to sequential expression of spasmolytic polypeptide, intestinal trefoil factor, epidermal growth factor and transforming growth factor alpha mRNAs in rat stomach
39. A robust method for isotopic riboprobe in situ hybridisation to localise mRNAs in routine pathology specimens
40. Altered expression of β-catenin, inducible nitric oxide synthase and cyclooxygenase-2 in azoxymethane-induced rat colon carcinogenesis
41. Increased in situ expression of nitric oxide synthase in human colorectal cancer
42. Differential expression of matrilysin and cyclooxygenase-2 in intestinal and colorectal neoplasms
43. Frequent β-catenin gene mutations and accumulations of the protein in the putative preneoplastic lesions lacking macroscopic aberrant crypt foci appearance, in rat colon carcinogenesis
44. Increased expression of inducible and endothelial constitutive nitric oxide synthases in rat colon tumors induced by azoxymethane
45. The Min (multiple intestinal neopiasia) mutation: Its effect on gut epithelial cell differentiation and interaction with a modifier system
46. Cox-2 in murine intestinal tumors
47. Suppression of intestinal polyposis by inhibition of cycloxygenase-2 in a mouse model for familial adenomatous polyposis
48. High expression of cyclooxygenase-2 in macrophages of human colonic adenoma
49. Expression of prostaglandin endoperoxide H synthase-2 induced by nitric oxide in conditionally immortalized murine colonic epithelial cells
50. Cyclooxygenase-2 overexpression and tumor formation are blocked by sulindac in murine model f familial adenomatous polyposis
51. Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis
52. The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis
53. Cyclooxygenase-independent chemoprevention with an aspirin derivative in a rat model of colonic adenocarcinoma